Chemokine release is associated with the protective action of PACAP-38 against HIV envelope protein neurotoxicity

Neuropeptides

Volumn 36, Issue 4, 2002, Pages 271-280

  Brenneman, Douglas E ^a   Hauser, Janet M ^a   Spong, Catherine Y ^a   Phillips, Terry M ^b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; GLYCOPROTEIN GP 120; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIBODY AFFINITY; ARTICLE; ASTROCYTE; CAPILLARY ELECTROPHORESIS; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN SECRETION; RAT; REGULATORY MECHANISM;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0036700820     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(02)00045-8     Document Type: Article

References (48)

1. Achim CL, Wang R, Miners DK, Wiley CA (1994) Brain viral burden in HIV-infection. J Neuropathol Exp Neurol 53: 284-294.
2. Altmeyer R, Mordelet E, Girard M, Vidal C (1999) Expression and detection of macrophage-tropic HIV-1 gp120 in the brain using conformation-dependent antibodies. Virology 259: 314-323.
3. Arimura A (1998) Perspectives on pituitary adenylate cyclase activating polypeptide (PACAP) in the neuroendocrine, endocrine, and nervous systems. Jpn J Physiol 48: 301-331.
4. Arimura A, Somogyvari-Vigh A, Weill C, Fiore RC, Tatsuno I, Bay V, Brenneman DE (1994) PACAP functions as a neurotrophic factor. Ann N Y Acad Sci 739: 228-243.
5. Ashur-Fabian O, Giladi E, Brenneman DE, Gozes I (1997) Identification of VIP/PACAP receptors on rat astrocytes using antisense oligodeoxynucleotides. J Mol Neurosci 9: 211-222.
6. Bagetta G, Corasaniti MT, Malorni W, Rainaldi G, Berliocchi L, FinazziAgro A, Nistico G (1996) The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. Neuroreport 7: 1722-1724.
7. Brenneman DE, Hauser J, Spong CY, Phillips TM, Pert CB, Ruff M (1999) VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 gp120-induced neuronal death. Brain Res 838: 27-36.
8. Brenneman DE, Hill JM, Glazner GW, Gozes I, Phillips T (1995) Interleukin-1 alpha and vasoactive intestinal peptide: Enigmatic regulation of neuronal survival. Int J Dev Neurosci 13: 187-200.
9. Brenneman DE, McCune SK, Gozes I (1990) Acquired immune deficiency syndrome and the developing nervous system. Int Rev Neurobiol 32: 305-353.
10. Brenneman DE, Neale EA, Foster GA, d'Autremont SW, Westbrook GL (1987) Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J Cell Biol 104: 1603-1610.
11. Brenneman DE, Westbrook GL, Fitzgerald SP, Ennist DL, Elkins KL, Ruff MR, Pert CB (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335: 639-642.
12. Budka H (1990) Human immunodeficiency virus (HIV) envelope and core proteins in CNS tissues of patients with the acquired immune deficiency syndrome (AIDS). Acta Neuropathol (Berl) 79: 611-619.
13. Choe H, Farzan M, Sun Y, Sullivan N, Rollins B, Ponath PD, Wu L, Mackay CR, LaRosa G, Newman W, Gerard N, Gerard C, Sodroski J (1996) The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 85: 1135-1148.
14. Christensen ST, Quie H, Kemp K, Rasmussen L (1996) Insulin produces a biphasic response in tetrahymena thermophila by stimulating cell survival and activating proliferation in two separate concentration intervals. Cell Biol Int 20: 437-444.
15. Dawson VL, Dawson TM, Uhl GR, Snyder SH (1993) Human-immunodeficiency-virus type-1 coat protein neurotoxicity mediated by nitric-oxide in primary cortical cultures. Proc Natl Acad Sci USA 90: 3256-3259.
16. Fatatis A, Holtzclaw LA, Avidor R, Brenneman DE, Russell JT (1994) Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with α-adrenergic receptors. Proc Natl Acad Sci USA 91: 2036-2040.
17. Giulian D, Yu J, Li X, Tom D, Li J, Wendt E, Lin SN, Schwarcz R, Noonan C (1996) Study of receptor-mediated neurotoxins released by HIV-1-infected mononuclear phagocytes found in human brain. J Neurosci 16: 3139-3153.
18. Glowa JR, Panlilio LV, Brenneman DE, Gozes I, Fridkin M, Hill JM (1992) Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist. Brain Res 570: 49-53.
19. Grimaldi M, Cavallaro S (1999) Functional and molecular diversity of PACAP/VIP receptors in cortical neurons and type I astrocytes. Eur J Neurosci 11: 2767-2772.
20. Hill JM, Harris A, Hilton-Clarke DI (1992) Regional distribution of guanine nucleotide-sensitive and guanine nucleotide-insensitive vasoactive intestinal peptide receptors in rat brain. Neuroscience 48: 925-932.
21. Hill JM, Mervis RF, Avidor R, Moody TW, Brenneman DE (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res 603: 222-233.
22. Horuk R, Martin AW, Wang Z, Schweitzer L, Gerassimides A, Guo H, Lu Z, Hesselgesser J, Perez HD, Kim J, Parker J, Hadley TJ, Peiper SC (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol 158: 2882-2890.
23. Jaworski DM (2000) Expression of pituitary adenylate cyclase-activating polypeptide (PACAP) and the PACAP-selective receptor in cultured rat astrocytes, human brain tumors and in response to acute intracranial injury. Cell Tissue Res 300: 219-230.
24. Jiang Y, Salafranca MM, Adhikari S, Xia YY, Feng LL, Sonntag MK, deFiebre CM, Pennell NA, Streit WJ, Harrison JK (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86: 1-12.
25. Jordan CA, Watkins BA, Kufta C, Dubois-Dalcq M (1991) Infection of brain microglial cells by human-immunodeficiency-virus type-1 is CD4 dependent. J Virol 65: 736-742.
26. Journot L, Waeber C, Pantaloni C, Holsboer F, Seeburg PH, Bockaert J, Spengler D (1995) Differential signal-transduction by 6 splice variants of the pituitary adenylate cyclase-activating peptide (PACAP) receptor. Biochem Soc Trans 23: 133-137.
27. Gozes I, Glowa J, Brenneman DE, McCune SK, Lee S, Westphal H (1993) Learning and sexual deficiences in transgenic mice carrying a chimeric vasoactive intestinal peptide gene. J Mol Neurosci 4: 185-193.
28. Kong L-Y, Maderdrut JL, Jeohn G-H, Hong J-S (1999) Reduction of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by femtomolar concentrations of pituitary adenylate cyclase-activating polypeptide. Neuroscience 91: 493-500.
29. Lipton SA (1992) Requirement for macrophages in neuronal injury induced by HIV envelope protein gp120. Neuroreport 3: 913-915.
30. Lipton SA, Sucher NJ, Kaiser PK, Dreyer EB (1991) Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicity. Neuron 7: 111-118.
31. Liu B, Qin L, Yang S-N, Wilson BC, Liu Y, Hong J-S (2001) Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Therap 298: 1133-1141.
32. McCarthy KD, de Vellis J (1980) Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J Cell Biol 85: 890-902.
33. Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ (1998) Chemokines regulate hippocampal neuronal signaling and gp 120 neurotoxicity. Proc Natl Acad Sci USA 95: 14500-14505.
34. Miller RJ, Meucci O (1999) AIDS and the brain: Is there a chemokine connection? Trends Neurosci 22: 471-479.
35. Nath A, Geiger J (1998) Neurobiological aspects of human immunodeficiency virus infection: Neurotoxic mechanisms. Prog Neurobiol 54: 19-33.
36. O'Donohue TL, Charlton CG, Miller RL, Boden G, Jacobowitz DM (1981) Identification, characterization, and distribution of secretin immunoreactivity in rat and pig brain. Proc Natl Acad Sci USA 78: 5221-5224.
37. Olah Z, Lehel C, Anderson WB, Brenneman DE, Agoston D (1994) Subnanomolar concentration of VIP induces the nuclear translocation of protein kinase C in neonatal rat cortical astrocytes. J Neurosci Res 39: 355-363.
38. Pantaloni C, Brabet P, Bilanges B, Dumuis A, Houssami S, Spengler D, Bockaert J, Garnet L (1996) Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem 271: 22146-22151.
39. Pert CB, Ruff MR, Hill JM (1988) AIDS as a neuropeptide disorder: peptide T, VIP, and the HIV receptor. Psychopharmacol Bull 24: 315-319.
40. Phillips TM (1992) Measurement of recombinant interferon levels by high performance immunoaffinity chromatography in body fluids of cancer patients on interferon therapy. Biomed Chromatogr 6: 287-290.
41. Phillips TM (1998) Determination of in situ tissue neuropeptides by capillary immunoelectrophoresis. Anal Chim Acta 372: 209-218.
42. Phillips TM (2001) Analysis of single-cell cultures by immunoaffinity capillary electrophoresis with laser-induced fluorescence detection. Luminescence 16: 145-152.
43. Phillips TM, Kimmel PL (1994) High-performance capillary electrophoretic analysis of inflammatory cytokines in human biopsies. J Chromatogr B, Biomed Appl 656: 259-266.
44. Romijn HJ, van Huizen F, Wolters PS (1984) Towards an improved serum-free, chemically defined medium for long-term culturing of cerebral cortex tissue. Neurosci Biobehav Rev 8: 301-334.
45. Schmechel D, Marangos PJ, Zis AP, Brightman M, Goodwin FK (1978) Brain endolases as specific markers of neuronal and glial cells. Science 199: 313-315.
46. Scorziello A, Florio T, Bajetto A, Schettini G (1998) Intracellular signalling mediating HIV-1 gp120 neurotoxicity. Cell Signal 10: 75-84.
47. Tatsuno I, Somogyvari-Vigh A, Arimura A (1994) Developmental changes of pituitary adenylate cyclase activating polypeptide (PACAP) and its receptor in the rat brain. Peptides 15: 55-60.
48. Wiley CA, Schrier RD, Nelson JA, Lampert PW, Oldstone MB (1986) Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83: 7089-7093.